It is appropriate for manufacturers to bear the costs of the evaluation needed to demonstrate that their products are safe to market and therefore a fee has to be paid to the authority designated by the Commission to examine the notifications for the active substances.
Recital 10, Commission Regulation (EC) No 1112/2002 of 20 June 2002 laying down the detailed rules f…
In force